HOME >> BIOLOGY >> NEWS
Insights Into The Proteasome - A Fascinating Macromolecular Machine For Protein Degradation

The proteasome is the central enzyme of the ATP-ubiquitin-dependent proteolytic pathway. It is responsible for the elimination of abnormal proteins, arising from mutations or damage ensuing from adverse external conditions. Moreover, it has important regulatory roles in numerous biological processes such as cell cycle, apoptosis or the immune response. A research team at the Max Planck Institute of Biochemistry in Martinsried/Germany, headed by Wolfgang Baumeister, since several years one of the leading groups in the proteasome field, has published a review-article in Cell on February 6, 1998, reflecting on the proteasome as one of the most fascinating macromolecular machines of the cell. The authors report on own data and review the current status of the topic.

Protein degradation is a necessity but also a hazard. It must be subject to precise spatial and temporal control to prevent that proteins not destined for degradation are attacked. A basic strategy in controlling protein degradation is compartmentalization, that is sequestration of proteolytic action from the environment. Many proteases reside within spezialized membrane-surrounded organelles, such as lysosomes. Another mechanism of control, which offers greater logistic flexibility, is self- or autocompartmentalization: proteolytic subunits self-associate into barrel-shaped complexes with inner cavities that harbour the active sites. The advances made in recent years in understanding the structure of the proteasome and its mechanism of action has helped to shape the concept of self-compartmentalization, and the proteasome became its paradigm.

The molecular species that functions in the ubiquitin-proteasome pathway is the so-called 26S proteasome, a large complex composed of approx. 35 different subunits. A smaller particle, the 20S
'"/>

Contact: Erika Seemller
seemuell@biochem.mpg.de
+49-89-8578-2634
Max-Planck-Gesellschaft
2-Mar-1998


Page: 1 2 3 4

Related biology news :

1. Insights on stroke from the peripheral blood suggest ways to develop markers and therapies
2. Insights gained from molecular modeling may lead to better insecticides
3. While the homeland is on alert, Technical Insights provides indispensable technology information
4. New Insights About Good Cholesterol
5. New Insights Into The Transport Machinery Of The Cell: A Single Protein Substitutes The Regulatory Machinery Specifying Endosome Fusion In Vitro
6. UNC-CH Groucho Research Offers Insights Into How Embryo, Cancer Cells Communicate
7. New Insights On Sequence of Cell Death After Brain Injury: Understanding Cellular Events After Brain Trauma Could Lead To Better Therapies
8. Gene Discovery Provides Insights Into Epilepsy
9. Fauci To Present New Insights Into HIV Latency At 12th World AIDS Conference
10. Very Fruitful Collaboration Between French And German Scientists Yields Unusual Insights Into The Structure Of Membrane Proteins
11. New Insights Into The Enigma Of Lengthening Longevity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... Today CJ ... Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient ... The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... solutions providers, today announced its strong opposition to the recently introduced bicameral ... a blanket ban on most federal use of nearly all biometric and related ...
Breaking Biology Technology:
Cached News: